Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.

Kreuz, Wolfhart; Gill, Joan C; Rothschild, Chantal; Manco-Johnson, Marilyn J; Lusher, Jeanne M; Kellermann, Elke; Gorina, Eduard; Larson, Peter J

Kreuz, Wolfhart; Gill, Joan C; Rothschild, Chantal; Manco-Johnson, Marilyn J; Lusher, Jeanne M; Kellermann, Elke; Gorina, Eduard; Larson, Peter J.

Affiliation

Kreuz W; The Center of Pediatrics III, Department of Hematology, Oncology and Hemostaseology, Johann Wolfgang Goethe-University Hospital, Frankfurt am Main, Germany. Wolfhart.Kreuz@kgu.de

Thromb Haemost ; 93(3): 457-67, 2005 Mar.

Article de En | MEDLINE | ID: mdl-15735795

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur VIII / Hémophilie A Type d'étude: Clinical_trials Limites: Child, preschool / Humans / Infant Langue: En Journal: Thromb Haemost Année: 2005 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Allemagne

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links